About Signal Fidelity Group

Built from the work.
Developed for what comes next.

Communications strategy and technology for businesses where precision is non-negotiable.

AI-created speaking portrait of Abhi Basu, founder of Signal Fidelity Group — AI-generated portrait illustration; not a photograph of a recorded speaking engagement.

Abhi Basu · Founder, Signal Fidelity Group

Global communications leadership. Built into what comes next.

Abhi Basu is a healthcare communications executive, AI strategist and founder of Signal Fidelity Group. His twenty-year career spans leadership at Johnson & Johnson MedTech, Takeda and Boston Scientific, alongside senior agency roles advising pharmaceutical and biotechnology companies. His responsibilities have included global product and pipeline communications for J&J’s $8 billion orthopaedics portfolio and ENTYVIO communications across more than 70 countries.

He led global communications for the launch of LIVTENCITY, advised executives on acquisitions and reputation, and built teams responsible for consequential product and business moments. He also helped bring AI into the communications function—building an AI-governed content architecture at J&J MedTech and founding Takeda’s AI in Communications community of practice.

With a background in neuroscience, Abhi brings a scientific lens to a practical communications question: how can AI extend a team’s strategic judgment and creative capacity without losing the meaning, evidence and intent behind the work? His research also examines the other side of that relationship: how context and sources shape AI’s representation of a company when it answers an audience’s questions.

His research and development includes four provisional patent applications and LIRA—the Looped Inference Regulation Architecture. LIRA is SFG’s closed-loop control architecture: it compares AI outputs with authorized meaning and evidence, detects where interpretation has drifted, and directs correction or human review. Its purpose is to make changes in meaning visible and actionable—not simply ask a model to be more careful.

That work informs CommsRx, SFG’s agentic platform for pharmaceutical and biotech communications—connecting strategic counsel, research, message adaptation and creative execution, with communications professionals directing the work.

The ambition: give communications teams greater capacity to think, create and act—without surrendering the judgment that makes the work valuable.

Leadership inside global healthcare.

In-house leadership at Johnson & Johnson, Takeda and Boston Scientific, alongside a wider career advising pharma, biotech and MedTech companies.

Logos identify experience from Abhi Basu’s prior in-house and agency roles; they do not indicate SFG client relationships or endorsements.

Global product & pipeline communications, Orthopaedics
Global communications, Immunology & Gastroenterology
Global communications, MedSurg

Experience behind the brands.

Selected medicines and medical technologies from Abhi’s communications work across in-house and agency roles.

Logos identify experience from Abhi Basu’s prior in-house and agency roles; they do not indicate SFG client relationships or endorsements.

Explore the full product portfolio

Stories that earn attention.

Across his in-house and agency career, Abhi has secured news coverage, features and cover stories for healthcare companies and products. Selected media placements include:

Selected media placements from Abhi’s communications career; not endorsements of SFG.